Compare Cytokinetics Inc (CYTK) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Pfizer Inc — how do they compare? Cytokinetics Inc trades at $81.99 (market cap $11.12B), while Pfizer Inc trades at $24.28 (market cap $138.21B). The key difference: Pfizer Inc is far larger — about 12.4× Cytokinetics Inc's market cap, and Pfizer Inc pays a 7.09% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | PFE | |
|---|---|---|
Market Cap | $11.12B | $138.21B |
Sector | Technology | Health |
52-Week High | $87.26 | $28.56 |
52-Week Low | $33.23 | $23.29 |
Enterprise Value | $11.59B | $188.87B |
Volume | — | 29,869,932 |
Dividend Yield | — | 7.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $24.25, up 0.33% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q1 2026 EPS of $0.75, beating expectations, and maintains a dividend of $0.43 per share. Recent news highlights Pfizer's focus on its obesity and oncology pipeline, with key catalysts expected in 2026. Financials show revenue of $62.58B in 2025, with a net income margin of 11.83% and a P/E ratio of 18.69.
The outlook for Pfizer is mixed, with analyst consensus leaning toward Hold (58.98%) but a price target of $28.78 suggesting potential upside. Investment opportunities include a strong dividend yield and pipeline advancements, while risks involve patent cliffs and competitive pressures. The stock's current valuation appears reasonable, but execution on pipeline developments is critical for future growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
